# OnCo record paper-her2climb-02-ann-oncol-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-her2climb-02-ann-oncol-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-her2climb-02-ann-oncol-2026" ;
  schema:name "Tucatinib and trastuzumab emtansine for patients with previously treated HER2-positive locally advanced and metastatic breast cancer: primary analysis of the randomized phase III trial HER2CLIMB-02"@en ;
  schema:description "Published report from the HER2CLIMB-02 trial registered as NCT03975647, in Annals of Oncology (2026), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-her2climb-02-ann-oncol-2026/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/j.annonc.2025.11.005>, <https://pubmed.ncbi.nlm.nih.gov/41260264/>, <https://europepmc.org/article/MED/41260264>, <https://clinicaltrials.gov/study/NCT03975647> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/j.annonc.2025.11.005> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Hurvitz SA, Loi S, O'Shaughnessy J, et al." ;
  onco:trials <https://onco.cc/trials/her2climb-02/> ;
  onco:journals <https://onco.cc/journals/annals-of-oncology/> .